“…In this regard, several inorganic, organic, and hybrid organic/inorganic structures such as mesoporous silica, zeolite, polymers, layered double hydroxide (LDH), CaO, and montmorillonites were evaluated as promising drug carriers for chemotherapies. ,,,, The previous materials demonstrated a significant effect in inducing the permeability and retention properties of the used drug. − ,, Hydroxyapatite is a promising biomaterial species of the apatite family that exhibits Ca 10 (PO 4 ) 6 (OH) 2 and is widely used in numerous medical industries including tissue and bone engineering as well as effective drug delivery structure. − This was assigned to its significant chemical stability, surface area, acid–base adjustability, ion exchange capacity, long shelf life, flexible structure, and adsorption capacity. − As a biomaterial, it is bioactive, biodegradable, biocompatible, and osteoconductive without causing inflammation and toxicity. ,, However, the hydrophilic properties of its structure reduce its efficiency as carriers of the common drugs that are off organic chemical structure. , Consequently, many studies have been established to improve the physical, chemical, and biological properties of HAP by controlling its morphology, chemical composition, and crystallite size in addition to its surface functionalization and hybridization by polymers and other active chemical groups. ,, The hybrid composites of HAP and the reactive natural or synthetic polymers can successfully overcome the reported drawbacks during the application of it as a delivery system including the low encapsulation capacity, uncontrollable release rate, high brittleness, easy agglomeration, and poor plasticity. , …”